期刊文献+

慢性主动脉周围炎临床分析 被引量:3

Analysis of clinical features of chronic periaortitis
原文传递
导出
摘要 目的了解我国慢性主动脉周围炎患者的临床特点,提高对该疾病的认识。方法对28例确诊慢性主动脉周围炎患者的临床资料进行回顾性分析,28例中男∶女=4·5∶1,平均年龄52·8岁。结果28例中20例(71·4%)为特发性腹膜后纤维化,5例(17·8%)为炎性腹主动脉瘤,3例(10·7%)为主动脉瘤周围腹膜后纤维化。最常见的症状是腹痛9例(35·7%)、腰痛7例(25%)、体重减轻7例(25%)、腹胀5例(17·8%)和下肢浮肿5例(17·8%)。CT和MRI检查发现腹膜后软组织影。10例患者是经病理学检查确诊。17例(85%)特发性腹膜后纤维化患者经B超声检查发现有肾积水,7例经B超声检查发现为腹主动脉扩张。20例中有8例进行手术治疗,17例采用糖皮质激素和/或免疫抑制剂和/或他莫昔芬治疗。1例合并强直性脊柱炎,1例合并未分化结缔组织疾病。无并发其他器官纤维化疾病者。5例炎性腹主动脉瘤患者均有典型影像学表现,其中3例经病理学检查证实。3例动脉瘤周围腹膜后纤维化患者均被误诊为特发性腹膜后纤维化或腹主动脉瘤。结论慢性主动脉周围炎是一种罕见自身免疫性风湿病,以特发性腹膜后纤维化为最多见。无特异临床症状,但可以合并自身免疫性风湿病或自身抗体,确诊有赖于影象学证据和病理学检查。糖皮质激素联合免疫抑制剂或他莫昔芬可以缓解病情。 Objective Understand the clinical features of chronic periaortitis. Methods The medical records of 28 cases with definite diagnosis of chronic periaortitis were reviewed retrospectively. Results Among these 28 cases, 20(71.4% ) fulfilled the diagnostic criteria of idiopathic retroperitoneal fibrosis(IPF), 5 ( 17. 8% ) were inflammatory abdominal aortic aneurysm (IAAA) and 3 ( 10. 7% ) were perianeurysmal retroperitoneal fibrosis (PARF). The common symptoms were abdominal blunt pain (35.7%), lumbago (25%), loss of body weight (25%), abdominal distension ( 17. 8% ) and lower extremities pitting edema( 17. 8% ). Hydronephrosis was found by B untrasonography in 17(85% ) patients with IPF. Dilated abdominal aorta were found in 7 patients. One case was complicated with ankylosing spondylitis and another one was diagnosed to have undifferentiated connective diseases. All 5 IAAA patients were treated by aneurysm segregation or stent implantation, but none had medical therapy. The 3 perianeurysmal retroperitoneal fibrosis patients were mis-diagnosed as with either IPF or AAA. Seventeen patients in this group were treated with corticosteroid combined with immunosuppressive agents or tamoxiferL Four cases were followed up and their conditions were improved which were demonstrated by repeated CT or MRI. Conclusion Chronic periaortitis is a rare autoimmune rheumatic disease. IPF is the most common one compared to IAAA and PARF. It can be complicated with autoimmune disorders or serum autoantibodies. No case with other organ fibrosis disorder wis observed in this study. Radiological examination and pathological examination are necessary for confirming the diagnosis. Corticosteroid combined with immunosuppressive agents or tamoxifen is the effective treatment.
出处 《中华医学杂志》 CAS CSCD 北大核心 2006年第15期1035-1039,共5页 National Medical Journal of China
关键词 慢性主动脉周围炎 临床特点 特发性腹膜后纤维化 炎性腹主动脉瘤 Retroperitoneal fibrosis Aortic aneurysm
  • 相关文献

参考文献15

  • 1Vaglio A,Buzio C.Chronic periaortitis:a spectrum of disease.Curr Opin Rheumatol,2005,17:34-40.
  • 2Haug ES,Skomsvoll IF,Jacobsen G,et al.Inflammatory aortic aneurysm is associated with increased incidence of autoimmune disease.J Vasc Surg,2003,38:492-497.
  • 3Walker DI,Bloor K,Williams G,et al.Inflammatory aneurysms of the abdominal aorta.Br J Surg,1972,59:609-614.
  • 4Mitchinson MJ.Chronic periaortitis and periaortitis.Histopathology,1984,8:589-600.
  • 5Gilkeson GS,Allen NB.Retroperitoneal fibrosis-a true connective tissue disease.Rheum Dis Clin North AM,1996,22:23-28.
  • 6Gilkeson GS,Allen NB.Retroperitonral fibrosis:a true connective tissue disease.Rheum Dis Clin North Am,1996,22:23-38.
  • 7蒋明,张思争,潘卫东,曾学军,张丕胜.特发性腹膜后纤维化七例临床分析[J].中华医学杂志,2002,82(3):186-188. 被引量:27
  • 8Uibu T,Oksa P,Auvinen A,et al.Asbestos exposure as a risk factor for retroperitoneal fibrosis.Lancet,2004,363:1422-1426.
  • 9Baker LR,Mallinson WJ,Gregory MC,et al.Idiopathic retroperitoneal fibrosis:a retrospective analysis of 60 cases.Br J Urol,1998,38:1685-1688.
  • 10Parums DV,Brown DL,Mitchinson MJ.Serum antibody to oxidized low density lipoprotein and ceroid in chronic periaortitis.Arch Pathol Lab Med,1990,114:383-387.

二级参考文献1

共引文献26

同被引文献29

  • 1van Bommel EF. Retroperitoneal fibrosis. Neth J Med, 2002,60 : 231-242.
  • 2Baker LR, Mallinson WJ, Gregory MC, et al. Idiopathic retroperitoneal fibrosis. A retrospective analysis of 60 cases. Br J Urol, 1987,60:497-503.
  • 3Vaglio A, Salvarani C, Buzio C. Retroperitoneal fibrosis. Lancet, 2006,367 : 241-251.
  • 4Fry AC, Singh S, Gunda SS,et al. Successful use of steroids and ureteric stems in 24 patients with idiopathic retroperitoneal fibrosis: a retrospective study. Nephron Clin Pract, 2008, 108: c213-220.
  • 5Vaglio A, l?almisano A, Corradi D, et al. Retroperitoneal fibrosis : evolving concepts. Rheum Dis Clin North Am,2007,33:803-817, vi-vii.
  • 6Kardar AH, Kattan S, Lindstedt E, et al. Steroid therapy for idiopathic retroperitoneal fibrosis: dose and duration. J Urol, 2002,168:550-555.
  • 7Loffeld R J, van Weel TF. Tamoxifen for retroperitoneal fibrosis. Lancet, 1993,341 : 382.
  • 8Al Rabi N, Graziani R, Cerruto MA, et al. Clinical and radiological evolution of a case of idiopathic retroperitoneal fibrosis treated with Tamoxifen. Scand J Urol Nephrol,2002 ,36 :391-392.
  • 9van Bommel EF, Siemes C, Hak LE, et al. Long-term renal and patient outcome in idiopathic retroperitoneal fibrosis treated with prednisone. Am J Kidney Dis,2007,49:615-625.
  • 10Harreby M, Bilde T, Helin P, et al. Retroperitoneal fibrosis treated with methylprednisolon pulse and disease-modifying antirheumatic drugs. Scand J Urol Nephrol, 1994,28:237-242.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部